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Background. Aspergillus fumigatus causes invasive aspergillosis, a potentially fatal infection in oncohematological
patients. Innate immune detection of A. fumigatus involves Toll-like receptor (TLR) 4 and TLR2, which forms
a heterodimer with either TLR1 or TLR6. The role of those coreceptors in Aspergillus sensing is unknown.
Methods. Cytokine production was measured in bone marrow–derived macrophages (BMDMs) from wild-type
(WT) and TLR-deficient mice after incubation with a WT and an immunogenic RodA-deficient (DrodA-47) strain of
A. fumigatus and in lungs from these mice after intranasal mold inoculation. Aspergillus fumigatus–mediated NF-jB
activation was measured in HEK293T cells transfected with plasmids expressing mouse or human TLRs.
Results. Bone marrow–derived macrophages from TLR1- and TLR6-deficient mice produced lower amounts of
interleukin 12p40, CXCL2, interleukin 6, and tumor necrosis factor a than BMDMs from WT mice after stimulation
with A. fumigatus. Lungs from TLR1- and TLR6-deficient mice had diminished CXCL1 and CXCL2 production and
increased fungal burden after intranasal inoculation of DrodA A. fumigatus compared with lungs from WT mice.
DrodA strain-mediated NF-jB activation was observed in HEK293T cells expressing mouse TLR2/1, mouse TLR2/6,
and human TLR2/1 but not human TLR2/6.
Conclusions. Innate immune detection of A. fumigatus is mediated by TLR4 and TLR2 together with TLR1 or
TLR6 in mice and TLR1 but not TLR6 in humans.
Aspergillus fumigatus is a ubiquitous mold that can cause
invasive aspergillosis (IA), a potentially lethal infection
in oncohematological patients. With an incidence rate
ranging 5%–15%, IA is one of the most frequent in-
fections in patients undergoing intensive myeloablative
chemotherapy for acute leukemia or allogenic hemato-
poietic stem cell transplantation [1]. Despite the avail-
ability of newer antifungal drugs, IA is still associated
with a high mortality (30%–60%) [2]. Understanding
the pathogenic mechanisms of IA may have important
consequences for the prevention and management of
this infection in patients at risk.
Strategically located at the host-pathogen interface,
Toll-like receptors (TLRs) are essential components of
the innate immune system. They constitute a family of
at least 12 transmembrane proteins localized either on
the cell surface (TLR1, 2, 4, 5, and 6) or within endocytic
vesicles (TLR3, 7, 8, and 9) of mammalian cells. The
extracellular domain of TLRs is characterized by the
presence of leucine-rich repeats that detect specific
microbe-associated molecular patterns [3]. Their in-
tracellular domain interacts with signaling molecules,
leading to the activation of transcription factors and
the release of soluble mediators such as cytokines and
chemokines that initiate and shape adaptative immune
response [4, 5].
The involvement of TLR2 and TLR4 in the innate
immune detection of A. fumigatus was suggested by
several studies measuring cytokine production from
bone marrow–derived macrophages (BMDMs) from
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wild-type (WT) and TLR-deficient mice [6–8], a study mea-
suring transfection of TLR plasmids into different cell-lines
[9], and in vivo models of IA [10, 11]. However, these ex-
periments were not univocally confirmed [9, 12, 13] and did
not assess the possible role of TLR1 and TLR6, known as
TLR2 coreceptors [14–16].
Recent studies show that A. fumigatus RodA protein, which
constitutes interwoven rodlet fascicles on the outermost cell
wall of conidia, prevents innate immune recognition and could
in part explain incongruity so far reported in literature [17, 18].
Aimanianda et al showed that removal of this protein from
A. fumigatus either chemically, genetically (by using a mutant
deficient in RodA, DrodA), or biologically (by germination) en-
hanced immune activation [17]. Human dendritic cells and
murine alveolar macrophages stimulated by dormant conidia
(DOC) from DrodA A. fumigatus produced large amounts of
tumor necrosis factor a (TNF-a), interleukin 6 (IL-6), interleukin
10 (IL-10), and interleukin 1b (IL-1b), whereas the same cells
stimulated by DOC from WT A. fumigatus produced almost
undetectable amounts of these cytokines [17].
In this study, we used the immunogenic rodletless mutant
strain of A. fumigatus (DrodA-47) to investigate the role of TLR1,
TLR2, TLR4, and TLR6 in the immune responses to A. fumigatus.
This strain was used together with WT A. fumigatus in cells from
knockout mice as well as HEK293T cells transfected with TLR
plasmids. We confirmed the role of TLR2 and TLR4 in the
innate immune detection of this pathogen in both mice and
humans and showed that this detection involves both TLR1 and
TLR6 in mice and TLR1 but not TLR6 in humans. Moreover, we
analyzed the role of TLR1 domains in the detection of this
pathogen in humans and also the functional effects of poly-
morphisms located in the coding region of TLR1 and previously




Mice deficient in TLR1, TLR2, TLR3, TLR4, and TLR6
(all from C57BL/6 background) were described elsewhere
[20–25]. Wild-type female C57BL/6 mice purchased from
Charles River Laboratories were used as controls. All
mice were bred and housed with filtered air under standard
conditions. All animal procedures were approved by the
Office Ve´te´rinaire du Canton de Vaud (authorizations
number 876.6 and 877.6) and performed according to the
institution’s guidelines for animal experiments.
Cells and Reagents
Human HEK293T cells (American Type Culture Collection
No. CRL-1573) were cultured in cellular grade Petri dishes
in Dulbecco’s modified Eagle medium (Invitrogen). Bone
marrow–derived macrophages and bone marrow–derived
dendritic cells (BMDCs) were obtained from femoral and
tibial bone marrow cells and cultured in Iscove’s modified
Dulbecco’s medium (Invitrogen) supplemented with monocyte
and granulocyte-monocyte colony-stimulating factor, res-
pectively [26]. All media were supplemented with 2 mmol/L
L-glutamine, 50 lmol/L 2-mercaptoethanol, 100 IU/mL of
penicillin, 100 lg/mL of streptomycin (all from Invitrogen)
and 10% heat-inactivated fetal calf serum (Sigma–Aldrich),
and cells were maintained in a humidified incubator at 37C
and 5% carbon dioxide. Adherent cells were harvested on
day 5 (HEK293) and day 7 (BMDMs and BMDCs), enu-
merated, and used for the experiments.
Stimulations were performed using 100 ng/mL of Salmonella
minnesota ultra pure lipopolysaccaride (LPS) (List Biological
Laboratories), 1–10 lg/mL palmitoyl-cys((RS)-2,3-di(palmi-
toyloxy)-propyl)-Ser-Lys-Lys-Lys-Lys-OHtrifluoro-acetate salt
(Pam3CSK4; EMC microcollections), 100 ng/mL of macro-
phage-activating lipopeptide-2 (MALP-2) (Invivogen), and
10 lg/mL polyinosine-polycytidylic acid (Invivogen) DOC
and germinated conidia (GC) from A. fumigatus Centraalbureau
voor Schimmelcultures, Utrecht, The Netherlands (CBS) 144-89
(WT) and DOC from A. fumigatus DrodA CBS 144-89 at
multiplicity of infection of 1. Dormant conidia were obtained
from 6-day cultures grown on Sabouraud agar plate at 37C.
Germinated conidia were obtained by incubating DOC for
up to 8 hours in Sabouraud liquid medium (2% glucose and 1%
mycopeptone) at 37C [17]. Conidia were killed by exposure to
2% paraformaldehyde (PFA) (4C, overnight).
Cytokine and Chemokine Quantification
Bone marrow–derived macrophages from WT and TLR-
deficient mice were incubated with WT and DrodA strains of
A. fumigatus and subsequently analyzed for cytokine expres-
sion and secretion after 4 hours and 24 hours, respectively.
This timing resulted in near maximal stimulation of cellular
responses. Total RNA was isolated from BMDMs using the
RNeasy kit (Qiagen). Reverse transcription of 1 lg of RNA
was performed using the ImProm II Reverse Transcription
System kit (Promega). Quantitative polymerase chain reac-
tion (PCR) was performed with a 7500 Fast Real-Time PCR
System using the Power SYBR Green PCR Master Mix
(PE Applied Biosystems) and primer pairs listed in Table 1.
All samples were tested in triplicate as described elsewhere
[27]. Gene-specific expression was expressed relative to the
expression of HPRT in arbitrary units (AU) (Table 1). Col-
lected cell-culture supernatants were processed for enzyme-
linked immunosorbent assay (ELISA) quantification of mouse
interleukin 12p40 (IL-12p40) and CXCL2 (R&D System).
In Vivo Infection Model
For infection assays, female mice aged 8–12 weeks (18–22 g)
were inoculated intranasally twice (6 hours apart) with 20 lL
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phosphate-buffered saline plus 0.05% of Tween 80 (Sigma-
Aldrich), either alone or mixed with 108 colony-forming units
(CFUs) of DOC. One day after inoculation, mice were eu-
thanized by carbon dioxide. Collected lungs were homoge-
nized in 2 mL of phosphate-buffered saline with a Medic
Tools tissue homogenizer. Chemokine expression and fungal
burden were quantified by CFU counts and quantitative real
time PCR (RT-PCR). Colony-forming units adjusted to the
weight of tissue were calculated by plating several dilutions of
tissue homogenates onto Sabouraud agar plates. The remaining
homogenate was used for quantitative PCR of cytochrome B
measurement as described above and using primer pairs listed in
Table 1.
DNA Expression Vectors
Wild-type and mutant human TLR1 (hTLR1) constructs were
kindly provided by T. R. Hawn (University of Washington,
Seattle [28]); human TLR1ext/TLR6int and TLR6ext/TLR1int
plasmids were provided by R. I. Tapping (University of
Illinois, Urbana [29]). Other plasmids were published else-
where (human TLR 2 [hTLR2], human TLR6 [hTLR6] and
human CD14 [hCD14] [30, 31]). Murine plasmids were
purchased from Invivogen (mouse TLR1 [mTLR1], mouse
TLR6 [mTLR6], and mouse CD14 [mCD14]) or described
elsewhere (mouse TLR 2 [mTLR2] [32]). Endothelial cell-
leukocyte adhesion molecule (ELAM) luciferase reporter
plasmid and transfection control pRL-TK plasmid were pur-
chased (Promega). Plasmids were amplified in Escherichia coli,
purified using the EndoFree Plasmid kit (Qiagen).
Luciferase Assay
The day before transfection, HEK293T cells were seeded at
2 3 104 cells per well in 96-well plates (Costar). Transient
transfection with 50 ng of ELAM plasmid, 5 ng of pRL-TK
plasmid, and 10 ng of each plasmid present in the mix was
performed using Effectene transfection reagent (Qiagen).
Equal DNA quantity was obtained by adding appropriate
amounts of empty plasmid. Toll-like receptor plasmid ex-
pression was confirmed by RT-PCR. Twenty-four hours after
transfection, cells were stimulated for 4 hours and lysed in
passive lysis buffer. Luciferase activity was measured using
the Dual-Luciferase Reporter Assay System (Promega) on
a FLUOstar Omega luminometer (BMG Labtech).
Statistical Analysis
The unpaired Student t test was used for statistical analysis
of experiments. Differences were considered statistically sig-
nificant at P , .05.
RESULTS
Murine TLR1 and TLR6 Mediate Immune Responses to
A. fumigatus
To determine the role of mTLR1 and mTLR6 in the innate
immune detection of A. fumigatus, we analyzed the pro-
duction of IL-12p40, CXCL2, IL-6, and TNF-a by BMDMs
from WT, TLR1-, TLR2-, TLR3-, TLR4-, and TLR6-deficient
mice in response to A. fumigatus. Bone marrow–derived
macrophages were incubated with a WT strain of A. fumigatus
(CBS 144-89) and a strain deficient in the RodA coating
protein (DrodA CBS 144-89), known for its strong immu-
nogenic properties. The production of IL-12p40, CXCL2,
IL-6, and TNF-a was measured by RT-PCR and ELISA.
Wild-type BMDMs stimulated with DOC from the DrodA
strain of A. fumigatus produced increased IL-12p40, CXCL2,
IL-6, and TNF- a protein (Figure 1) and messenger RNA
(mRNA) (Supplementary Figure 1 A–D) levels compared
with those stimulated with DOC from the WT strain.
Interleukin 12p40, CXCL2, IL-6, and TNF-a production
induced by both WT and DrodA strains of A. fumigatus
Table 1. Oligonucleotides Used in Reverse-Transcription Polymerase Chain Reaction Analyses
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was decreased in BMDMs deficient in TLR1 and almost aboli-
shed in BMDMs deficient in TLR2, TLR4, and TLR6, but not
TLR3, compared with WT BMDMs (Figure 1). As a control,
the ability of WT and TLR-deficient cells to produce these
cytokines was assessed by stimulation with specific TLR
agonists: LPS (TLR4 ligand), Pam3CSK4 (TLR1/2 ligand),
and MALP-2 (TLR6/TLR2 ligand) (data not shown). Similar
results were obtained in another experiment measuring
IL-6 production by BMDCs, instead of BMDMs, from TLR-
deficient mice after A. fumigatus stimulation (Supplementary
Figure 1 E–F).
To assess the role of TLR1 and TLR6 during the germi-
nating phase of the mold, which is mimicked by deletion
of the rodlet layer, we compared the immune responses
after stimulation with GC and DOC from the WT strain of
A. fumigatus as well as DOC from the DrodA strain. Bone
marrow–derived macrophages stimulated with both GC
from the WT strain and DOC from the DrodA strain pro-
duced increased levels of IL-12p40 and CXCL2 compa-
red with those stimulated with DOC from the WT strain
(Figure 2). Furthermore, BMDMs deficient in TLR1 and
TLR6 showed impaired production of IL-12p40 and CXCL2
after stimulation with all 3 different forms of A. fumigatus
(Figure 2). Altogether, these data suggest that the innate im-
mune detection of A. fumigatus in mice involves TLR1, TLR2,
TLR4, and TLR6 and that the DRodA strain of A. fumigatus
has an activation pattern similar to that of WT GC.
To further assess the role of TLR1 and TLR6 in the innate
immune detection of A. fumigatus, we used an in vivo infection
model of A. fumigatus pneumonia. CXCL1 and CXCL2 mRNA
expression, as well as A. fumigatus burden, was measured in
lungs from WT, TLR1-, TLR2-, TLR4-, and TLR6-deficient mice
Figure 1. Murine Toll-like receptor (TLR) 1, TLR2, TLR4, and TLR6 are required to produce interleukin 12p40 (IL-12p40), CXCL2, interleukin 6 (IL-6), and tumor
necrosis factor a (TNF-a) in response to wild-type (WT) and DrodA Aspergillus fumigatus. Bone marrow–derived macrophages from WT, TLR12/2, TLR22/
2,TLR32/2, TLR42/2, and TLR62/2 mice were incubated for 24 hours with 2% PFADrodA A. fumigatus (multiplicity of infection [MOI], 1) and WTA. fumigatus
(MOI, 1). IL-12p40 (A ), CXCL2 (B ), IL-6 (C ), and TNF-a (D ) secretion was quantified by enzyme-linked immunosorbent assay. Data are means 6 standard
deviations of triplicates from 1 experiment representative of 3 experiments. Abbreviations: PBS, phosphate-buffered saline; PFA, paraformaldehyde.
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24 hours after intranasal inoculation of DrodA A. fumigatus.
In lungs from WT mice, the infection strongly increased
CXCL1 and CXCL2 mRNA levels (Figure 3A and 3B), whereas
the mold was nearly undetectable as revealed by CFU counts
and RT-PCR detecting A. fumigatus cytochrome B gene
(Figure 3C and 3D). In lungs from TLR1-, TLR2-, TLR4-, and
TLR6-deficient mice, the expression of CXCL1 and CXCL2
mRNA was dramatically reduced (Figure 3A and 3B), whereas
large amounts of the mould were found in lung homogenates
(Figure 3C and 3D). Similarly, lungs from TLR1- and TLR6-
deficient mice infected with the WT (instead of the DrodA)
strain of A. fumigatus showed an increased fungal bur-
den compared with lungs from WT mice (Figure 3E). The
presence of conidia in lungs was confirmed by staining of
frozen tissue sections with Blankophor (not shown) [33].
To determine the influence of TLRs on mortality, TLR1- and
TLR6-deficient mice as well as WT mice (4 each) were infected
with WT and DrodA A. fumigatus as described above and fol-
lowed up for 30 days. Survival rate was 100% in TLR1- and TLR6-
deficient mice as well as in WT mice. Altogether, these results
suggest that the absence of TLR1, TLR2, TLR4, and TLR6 causes
impaired production of inflammatory mediators in response to
the mold and delayed fungal clearance. However, the absence of
TLR1 or TLR6 does not induce mortality in this model.
Mediation of Immune Responses to A. fumigatus by Human TLR1
but Not TLR6
To compare the role of human and mouse TLR1 and TLR6 in
the innate immune detection of A. fumigatus, HEK293T cells
were transiently transfected with vectors expressing human
Figure 2. Mouse Toll-like receptor (TLR) 1 and TLR6 are required to express and secrete interleukin 12p40 (IL-12p40) and CXCL2 in response to wild-type (WT)
and DrodA Aspergillus fumigatus dormant (DOC) conidia and WTA. fumigatus germinated conidia. Bone marrow–derived macrophages from WTand TLR1- and
TLR6-deficient mice were incubated for 4 hours (A, B ) or 24 hours (C, D ) with 2% PFA DrodA A. fumigatus DOC, WT A. fumigatus DOC, and germinated conidia
(GC) at a multiplicity of infection of 1. Expression of IL-12p40 and CXCL2 was measured by reverse-transcription polymerase chain reaction (A, B ), and secretion
was quantified by enzyme-linked immunosorbent assay (C, D ). Data are means 6 standard deviations of triplicates from 1 experiment representative of
3 experiments. Abbreviations: AU, arbitrary units; mRNA, messenger RNA; PBS, phosphate-buffered saline; PFA, paraformaldehyde.
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Figure 3. Toll-like receptor (TLR) 1-, TLR2-, TLR4-, and TLR6-deficient mice show impaired chemokines expression in response to Aspergillus fumigatus
and increased fungal burden in lungs compared with wild-type (WT) mice. Wild-type, TLR12/2, TLR22/2, TLR42/2, and TLR62/2mice were infected
twice, 6 hours apart, with 108 colony-forming units (CFUs) of DrodA (A–E ) or WT (E ) A. fumigatus. Twenty-four hours after infection lungs were collected
and tested for CXCL1 and CXCL2 messenger RNA (mRNA) expression by reverse-transcription polymerase chain reaction (RT-PCR) (A, B ). Lung
homogenates were plated onto Sabouraud agar plates for CFU counts (C, E ) and analyzed for quantification of A. fumigatus cytochrome B copy number by
RT-PCR (D ). Abbreviation: PBS, phosphate-buffered saline.
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and mouse TLR1 and TLR6 (each in combination with TLR2
and CD14 from the corresponding species), together with
a NF-jB luciferase reporter (ELAM) and a transfection control
(pRL-TK). The day after transfection, cells were incubated for
4 hours with WT or DrodA A. fumigatus or appropriate
controls, and luciferase activity was measured. Both strains
of A. fumigatus induced NF-jB activation in cells expressing
the mTLR2/mTLR1) (Figure 4A) and the hTLR2/hTLR1
(Figure 4B) combination, as well as the mTLR2/mTLR6 com-
bination (Figure 4C) but not the hTLR2/hTLR6 combination
(Figure 4D). Cells expressing either the human or mouse TLR2/
TLR1 combination were able to respond to Pam3CSK4 (TLR2/
TLR1 ligand) but not to MALP-2 (TLR2/TLR6 ligand) (Figure 4A
and 4B). Cells expressing the human or mouse TLR2/TLR6
combination showed NF-jB activation in response to MALP-2
but not to Pam3CSK4 stimulation (Figure 4C and 4D). These
results suggest that detection of A. fumigatus in mice requires
the presence of TLR2 together with TLR1 or TLR6, whereas
detection in humans relies on TLR2 along with TLR1 but
not TLR6.
To further ascertain the role of TLR1 and TLR6 in the
detection of A. fumigatus in human, HEK293T cells were
Figure 4. Innate immune response to wild-type (WT) and DrodA Aspergillus fumigatus is mediated by murine Toll-like receptor (TLR) 2/TLR1
(mTLR2/mTLR1) or TLR2/TLR6 (mTLR2/mTLR6) heterodimers and human TLR2/TLR1 (hTLR2/hTLR1). HEK293T cells were transfected with murine and
human TLR1 and TLR2 (A, B ) or murine and human TLR2 and TLR6 (C, D ) alone or together with murine (mCD14) and human CD14 (hCD14). Cells were
cotransfected with the ELAM luciferase and pRL-TK plasmids. The next day, cells were incubated for 4 hours with phosphate-buffered saline (PBS),
Pam3CSK4 (1 lg/mL) (A, B ), MALP-2 (100 ng/mL) (C, D). Wild-type or DrodA A. fumigatus (multiplicity of infection, 1) results are expressed as the ratio of
luciferase to Renilla luciferase activity (relative luciferase units [RLU]). Data are means 6 standard deviations of triplicates from 1 experiment
representative of 3 experiments. Abbreviations: ELAM, endothelial cell-leukocyte adhesion molecule; MALP-2, macrophage-activating lipopeptide-2.
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transfected with hTLR2 in combination with chimeric con-
structs carrying the extracellular domain from hTLR1 with
the intracellular domain from hTLR6 (hTLR1ext/TLR6int) or
the extracellular domain from hTLR6 with the intracellular
domain of hTLR1 (hTLR6ext/hTLR1int) (Figure 5A and 5B).
Wild-type and DrodA A. fumigatus induced NF-jB activation
in cells expressing chimeric TLRs carrying the extracellular
domain from TLR1 (hTLR1ext/TLR6int) but not in those
carrying the extracellular domain from TLR6 (hTLR6ext/
hTLR1int) (Figure5A and 5B). As a control, Pam3CSK4 in-
duced NF-jB activation in cells expressing chimeric TLRs
carrying the extracellular domain from TLR1 (hTLR1ext/
hTLR6int), and MALP-2 induced NF-jB activation in those
carrying the extracellular domain from TLR6 (hTLR6ext/
hTLR1int), as described elsewhere [29]. Altogether, these data
show that TLR1, but not TLR6, mediates the innate immune
detection of A. fumigatus in humans and that the extracellular
domain of human TLR1 is required for this detection.
Because TLR1 is involved in the innate immune response
to A. fumigatus in humans, we investigated the functional role
of 2 common genetic polymorphisms located in the coding
region of TLR1, G1805T (S602I; minor allele frequency
[MAF], 0.25 in whites) and G239C (R80T; MAF, 0.06 in
whites), which have been previously associated with suscepti-
bility to IA [19] and/or with impaired TLR1 function [28, 34].
Figure 5. Extracellular domain of human Toll-like receptor (TLR) 1
(hTLR1) and G1805T (S602I) and G239C (R80T) polymorphism can
modulate NF-jB activation on stimulation with wild-type (WT) and DrodA
Aspergillus fumigatus. A, Wild-type hTLR1 and human TLR6 (hTLR6)
plasmids carry human complementary DNA (cDNA) cloned into a construct
with V5 epitope TAG (pEF6-V5His-TOPO, Invivogen). Chimeric plasmids
carry hTLR1 extracellular and transmembrane domains merged with TLR6
intracellular domain (hTLR1ext/hTLR6int) or hTLR6 extracellular and
transmembrane domains merged with TLR1 intracellular domain
(hTLR6ext/hTLR1int). Human TLR1 haplotype plasmids carry a WT version
of TLR1 from human cDNA cloned into a construct with V5 epitope TAG
(pEF6-V5His-TOPO; Invivogen) that has been genetically modified using
site-directed mutagenesis (QuikChange Site-Directed Mutagenesis;
Stratagene) to reproduce all possible haplotypic combinations of
G1805T (S602I), located in the transmembrane junction, and G239C
(R80T), located in the ectodomain. B, C, HEK293T cells were transfected
with different mixes of plasmids, as indicated. B, In all conditions, cells
were transfected with endothelial cell-leukocyte adhesion molecule
Figure 5 continued. (ELAM) and pRL-TK together with empty vector or
human TLF1 (hTLR2) and human CD14 (hCD14). As reported, cells have
been complemented also with chimeric plasmids hTLR1ext/hTLR6int or
hTLR6ext/hTLR1int or WT hTLR1 or hTLR6, as control. C, In all conditions,
cells were transfected with ELAM and pRL-TK together with empty vector
or hTLR2 and hCD14. As reported, cells have been also transfected with
plasmids carrying WT hTLR1 (80R 602S) and all hTLR1 haplotypes (80R
602I, 80T 602S; 80T 602I). One day after transfection, cells were
incubated for 4 hours with phosphate-buffered saline (PBS), Pam3CSK4
(1 lg/mL), MALP-2 (100 ng/mL), or DrodA A. fumigatus (multiplicity of
infection 1), as indicated. NF-jB activation was measured by the
luminescent activity of a NF-jB firefly luciferase reporter plasmid
(relative luciferase units [RLU'). Data are means6 standard deviations of
triplicates from 1 experiment representative of 3 experiments.
Supplementary Figure 1. Mouse Toll-like receptor (TLR) 1, TLR2, TLR4,
and TLR6 are required to express interleukin 12p40 (IL-12p40), CXCL2,
interleukin 6 (IL-6), and tumor necrosis factor a (TNF-a) in response to
wild-type (WT) and DrodA Aspergillus fumigatus. Bone marrow–derived
macrophages (BMDMs) (A–D ) and bone marrow–derived dendritic cells
(BMDCs) (E–F ) from WT, TLR12/2, TLR22/2, TLR32/2, TLR42/2, and
TLR62/2 mice were incubated for 4 hours with 2% PFA DrodA
A. fumigatus (multiplicity of infection [MOI], 1) and WT A. fumigatus
(MOI, 1). For BMDMs, expression of IL-12p40 (A ), CXCL2 (B ), IL-6 (C ), and
TNF-a (D ) was measured by reverse-transcription polymerase chain
reaction (RT-PCR). For BMDCs, expression (E ) and secretion (F ) of IL-6 was
measured by RT-PCR and enzyme-linked immunosorbent assay, res-
pectively. Data are means 6 standard deviations of triplicates from 1
experiment representative of 3 experiments. Abbreviations: AU, arbitrary
units; mRNA, messenger RNA; PBS, phosphate-buffered saline.
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HEK293T cells were transfected with hTLR1 plasmids con-
taining the 4 haplotypic combinations of G1805T (S602I)
and G239C (R80T) (Figure 5A and 5C). HEK293T trans-
fected with plasmids carrying the 602I allele showed higher
levels of NF-jB activation at baseline and after stimulation
with WT and DrodA A. fumigatus compared with those
carrying the 602S allele. Cells transfected with plasmids
carrying the 80T allele revealed lower levels of NF-jB acti-
vation after stimulation with WT and DrodA A. fumigatus
compared with those carrying the 80R allele. These results
suggest that hTLR1 variants modulate innate immune res-
ponses to A. fumigatus.
DISCUSSION
In this study, we investigated the role of TLRs in the innate
immune detection of A. fumigatus in mice and humans.
Previous studies suggested a role for TLR2 and TLR4 in the
detection of this pathogen [6, 8, 12], but these observations
were not univocally confirmed [9, 12]. Moreover, limited
information was available on the role of TLR1 and TLR6,
which both dimerize with TLR2 for signaling [14–16]. We
showed that the detection of A. fumigatus is mediated by
TLR1 and TLR6 in mice and TLR1 but not TLR6 in humans,
together with TLR2 in both species. Our data also confirm
the role of TLR4 in both mice and humans.
Immune studies of A. fumigatus are complicated by the
evolving composition of its cell wall during its growth,
thereby conferring different immunological properties to the
pathogen [35]. Investigators used different growth stages of
the fungus (ie, resting conidia [8, 12], swollen conidia [12],
or hyphae [6, 8, 12]). Resting conidia produce a rodlet layer,
which constitutes a mechanical protection from immune
cells, leading to weak, almost undetectable, innate immune
responses [17]. The weak immunogenicity of the fungus, at
least during this early step, may explain why some studies
failed to detect the involvement of TLR2 [9], TLR4 [9, 12],
and MyD88 [9, 13]. In the present study, we used a mutant
form of A. fumigatus (DrodA), which does not produce this
masking layer and mimics the more immunogenic, germinated
form of the fungus [17]. Dormant conidia from this immuno-
genic strain produced similar, but stronger, immune responses
than the WT strain.
Species-specific differences in TLR ligand detection have
been described elsewhere. Mice but not humans can detect
taxol through TLR4 [36], trilauroylated peptides through
TLR2 [37], and LPS from Leptospira through TLR4 [38].
Phylogenetic studies suggest that the different TLRs arose
from $1 common ancestor by gene duplications events and
subsequent deletions and substitutions [39, 40]. It was
proposed that the TLR1 family (including TLR1, TLR2,
TLR6, and TLR10) underwent more species-specific changes
during evolution compared with other families [41]. Human
TLR1 and TLR6 are closely located on chromosome 4 [39],
suggesting a gene duplication event. As for the other TLRs,
the TIR signaling domains of TLR1 and TLR6 have more
sequence homology (96% in paralogs and 80% in orthologs)
than the leucine-rich repeat (LRR) ligand discriminating do-
mains (71% and 46%, respectively) [42]. This suggests that
the adaptive pressure shaped the ligand binding site to im-
prove the recognition and the defense against host-specific
pathogens. This is consistent with our transfection experiments
using TLR1/TLR6 chimeric plasmids, showing that TLR1, but
not TLR6, was able to detect A. fumigatus in humans, and that
this specificity was conferred by the TLR1 external LRR-con-
taining, but not internal TIR-containing, domain.
The multiplicity of pattern-recognition receptors (PRRs)
targeting the mold would suggest that the innate immune
recognition is redundant and that deficiency in a single PRR
would only account for a moderate effect. However, con-
sistent with previous observations [43], our data show that
the absence of a single PRR or adaptor protein leads to
a relatively strong impairment of cytokine production on A.
fumigatus stimulation and/or an important increase in the
fungal burden after infection. In fact, the activation of several
PRRs (either simultaneously or at different times of the in-
fection) may be necessary for appropriate immune responses.
This strategy may be adopted by the innate immune system to
avoid continuous and deleterious activation of inflammatory
responses to a pathogen to which we are exposed on a daily
basis, such as A. fumigatus.
It is not known whether this innate immune signal requires
a single ligand or multiples ligands from A. fumigatus nor
whether different TLRs are activated by the same or by dis-
tinct ligands. Some ligands were shown to be detected by
both TLR1/2 and TLR2/6 heterodimers (such as Ureaplasma
parvum lipoprotein and Chlamydia trachomatis elementary
bodies [44, 45]), but others are restricted to TLR1/2 (triacylated
lipopeptides and lipoarabinomannan [23, 46]) or TLR2/6
(diacylated lipopeptides [22]) heterodimers. However, identifi-
cation of A. fumigatus exact ligand(s) may be limited by the
ability to effectively isolate components of the pathogen’s cell
wall and intracellular compartment.
Identification of the PRRs involved in the innate immune
detection of A. fumigatus may have important consequences
for patient management. Single nucleotide polymorphisms
in the TLR4 gene from hematopoietic stem cell trans-
plantation donors have been associated with an increased
susceptibility to IA in the recipient [47]. We examined the
functional role of 2 TLR1 single nucleotide polymorphisms
located in the extracellular domain (G239C, R80T) and in the
junction of the transmembrane and intracellular domain
(G1805T, S602I) that were described in a report of a genetic
study on susceptibility to IA [34]. Our work shows that TLR1
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80T is associated with a lower NF-jB activation than TLR1 80R.
This is consistent with the findings of the genetic study,
showing that 80T is associated with an increased risk of IA
[19]. Our experiments showed that TLR1 602I leads to
higher NF-jB activation in response to A. fumigatus than
TLR1 602S. This is consistent with other studies showing
that TLR1 602I confers a better transmembrane expression
of the receptor than TLR1 602S and is protective against
leprosy [28, 34]. R80T is located in the highly conserved
extracellular domain of TLR1 shown to be necessary for
TLR1 ligand recognition. One can speculate that this poly-
morphism has an important impact on the folding of the
LRR domain, leading to an impairment of ligand binding
and/or TLR1 function, as already described for other TLRs
[48, 49]. Our results may contribute to explain the genetic
variability in susceptibility to IA and develop new preventing
strategies in high-risk patients [19, 47].
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